Maeshima K - Search Results

1

Human mesenchymal stem cells inhibit osteoclastogenesis through osteoprotegerin production.

Oshita K, Yamaoka K, Udagawa N, Fukuyo S, Sonomoto K, Maeshima K, Kurihara R, Nakano K, Saito K, Okada Y, Chiba K, Tanaka Y. Oshita K, et al. Among authors: maeshima k. Arthritis Rheum. 2011 Jun;63(6):1658-67. doi: 10.1002/art.30309. Arthritis Rheum. 2011. PMID: 21360521 Free article.

2

The JAK inhibitor tofacitinib regulates synovitis through inhibition of interferon-γ and interleukin-17 production by human CD4+ T cells.

Maeshima K, Yamaoka K, Kubo S, Nakano K, Iwata S, Saito K, Ohishi M, Miyahara H, Tanaka S, Ishii K, Yoshimatsu H, Tanaka Y. Maeshima K, et al. Arthritis Rheum. 2012 Jun;64(6):1790-8. doi: 10.1002/art.34329. Epub 2011 Dec 6. Arthritis Rheum. 2012. PMID: 22147632 Free article.

3

[Regulation of inflammation through JAK3-Stat6 pathway in dendritic cells].

Yamaoka K, Maeshima K, Kubo S, Tanaka Y. Yamaoka K, et al. Among authors: maeshima k. Nihon Rinsho Meneki Gakkai Kaishi. 2012;35(1):62-8. doi: 10.2177/jsci.35.62. Nihon Rinsho Meneki Gakkai Kaishi. 2012. PMID: 22374445 Free article. Review. Japanese.

4

[Anti-rheumatic effect of JAK-inhibitors].

Yamaoka K, Maeshima K, Kubo S, Sonomoto K, Tanaka Y. Yamaoka K, et al. Among authors: maeshima k. Nihon Rinsho Meneki Gakkai Kaishi. 2012;35(2):112-7. doi: 10.2177/jsci.35.112. Nihon Rinsho Meneki Gakkai Kaishi. 2012. PMID: 22576568 Free article. Japanese.

5

In vitro and in vivo analysis of a JAK inhibitor in rheumatoid arthritis.

Tanaka Y, Maeshima K, Yamaoka K. Tanaka Y, et al. Among authors: maeshima k. Ann Rheum Dis. 2012 Apr;71 Suppl 2:i70-4. doi: 10.1136/annrheumdis-2011-200595. Ann Rheum Dis. 2012. PMID: 22460142 Clinical Trial.

6

Effects of tofacitinib on lymphocytes in rheumatoid arthritis: relation to efficacy and infectious adverse events.

Sonomoto K, Yamaoka K, Kubo S, Hirata S, Fukuyo S, Maeshima K, Suzuki K, Saito K, Tanaka Y. Sonomoto K, et al. Among authors: maeshima k. Rheumatology (Oxford). 2014 May;53(5):914-8. doi: 10.1093/rheumatology/ket466. Epub 2014 Jan 17. Rheumatology (Oxford). 2014. PMID: 24441153 Clinical Trial.

7

l-Leucine influx through Slc7a5 regulates inflammatory responses of human B cells via mammalian target of rapamycin complex 1 signaling.

Torigoe M, Maeshima K, Ozaki T, Omura Y, Gotoh K, Tanaka Y, Ishii K, Shibata H. Torigoe M, et al. Among authors: maeshima k. Mod Rheumatol. 2019 Sep;29(5):885-891. doi: 10.1080/14397595.2018.1510822. Epub 2018 Sep 5. Mod Rheumatol. 2019. PMID: 30092695

8

An Adult Fatal Case with a STAT1 Gain-of-function Mutation Associated with Multiple Autoimmune Diseases.

Maeshima K, Ishii K, Shibata H. Maeshima K, et al. J Rheumatol. 2019 Mar;46(3):325-327. doi: 10.3899/jrheum.180210. Epub 2018 Nov 15. J Rheumatol. 2019. PMID: 30442829 No abstract available.

9

Dr. Maeshima, et al, reply.

Maeshima K, Okada S, Shibata H. Maeshima K, et al. J Rheumatol. 2019 Jun;46(6):655-656. doi: 10.3899/jrheum.181455. J Rheumatol. 2019. PMID: 31154449 No abstract available.

10

Adult-onset Still's disease with macrophage activation syndrome successfully treated with a combination of methotrexate and etanercept.

Maeshima K, Ishii K, Iwakura M, Akamine M, Hamasaki H, Abe I, Haranaka M, Tatsukawa H, Yoshimatsu H. Maeshima K, et al. Mod Rheumatol. 2012 Feb;22(1):137-41. doi: 10.1007/s10165-011-0477-9. Epub 2011 Jun 14. Mod Rheumatol. 2012. PMID: 21670967

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

706 results

Search Page

Filters